Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Income (2016 - 2025)

Fortress Biotech has reported Net Income over the past 13 years, most recently at -$5.5 million for Q4 2025.

  • Quarterly results put Net Income at -$5.5 million for Q4 2025, up 79.03% from a year ago — trailing twelve months through Dec 2025 was -$54.4 million (up 53.13% YoY), and the annual figure for FY2025 was -$33.0 million, up 72.66%.
  • Net Income for Q4 2025 was -$5.5 million at Fortress Biotech, down from $8.8 million in the prior quarter.
  • Over the last five years, Net Income for FBIO hit a ceiling of $8.8 million in Q3 2025 and a floor of -$62.3 million in Q4 2021.
  • Median Net Income over the past 5 years was -$35.8 million (2024), compared with a mean of -$35.5 million.
  • Biggest five-year swings in Net Income: plummeted 159.57% in 2021 and later skyrocketed 133.07% in 2025.
  • Fortress Biotech's Net Income stood at -$62.3 million in 2021, then grew by 7.92% to -$57.4 million in 2022, then soared by 49.89% to -$28.8 million in 2023, then increased by 8.54% to -$26.3 million in 2024, then skyrocketed by 79.03% to -$5.5 million in 2025.
  • The last three reported values for Net Income were -$5.5 million (Q4 2025), $8.8 million (Q3 2025), and -$35.9 million (Q2 2025) per Business Quant data.